Insider · CIK 0001806920
Snehal Patel
Files at GLSI (Greenwich LifeSciences, Inc.). First filing Jan 2, 2025, latest Jan 15, 2026.
Snehal Patel files SEC Form 4 as CEO, CFO, director and 10% owner at GLSI (Greenwich LifeSciences, Inc.). Since Jan 2, 2025, Snehal Patel has reported 18 open-market buys worth $856k and 0 open-market sells worth $0, the latest filed on Jan 15, 2026.
A track record needs three past buys with six months of prices behind them; Snehal Patel has 0, so none is measured yet.
The newest scored trade: bought $54k of GLSI on Jan 13, 2026, filed Jan 15, 2026, scored 32 (weak). In the last 12 months: 8 buys worth $489k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GLSI: Greenwich LifeSciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | GLSIbuy Greenwich LifeSciences, Inc. | $54k 1,800 shares | +0% | +270% from low0% from high | |
| 34Weak | GLSIbuy Greenwich LifeSciences, Inc. | $80k 2,900 shares | +0% | +242% from low0% from high | |
| 38Weak | GLSIbuy Greenwich LifeSciences, Inc. | $92k 4,300 shares | +0% | +168% from low-15% from high | |
| 33Weak | GLSIbuy Greenwich LifeSciences, Inc. | $63k 2,900 shares | +0% | +179% from low-12% from high | |
| 32Weak | GLSIbuy Greenwich LifeSciences, Inc. | $52k 4,100 shares | +0% | +58% from low-10% from high | |
| 49Moderate | GLSIbuy Greenwich LifeSciences, Inc. | $39k 4,600 shares | +0% | +7% from low-44% from high | |
| 52Moderate | GLSIbuy Greenwich LifeSciences, Inc. | $89k 10,600 shares | +0% | +7% from low-42% from high | |
| 38Weak | GLSIbuy Greenwich LifeSciences, Inc. | $21k 2,300 shares | +0% | +5% from low-38% from high | |
| 39Weak | GLSIbuy Greenwich LifeSciences, Inc. | $36k 3,600 shares | +0% | +13% from low-35% from high | |
| 50Moderate | GLSIbuy Greenwich LifeSciences, Inc. | $48k 5,400 shares | +0% | +1% from low-41% from high | |
| 49Moderate | GLSIbuy Greenwich LifeSciences, Inc. | $33k 3,600 shares | +0% | +9% from low-37% from high | |
| 50Moderate | GLSIbuy Greenwich LifeSciences, Inc. | $48k 5,500 shares | +0% | 0% from low-42% from high | |
| 30Weak | GLSIbuy Greenwich LifeSciences, Inc. | $31k 2,500 shares | +0% | - | |
| 31Weak | GLSIbuy Greenwich LifeSciences, Inc. | $39k 2,900 shares | +0% | - | |
| 31Weak | GLSIbuy Greenwich LifeSciences, Inc. | $44k 3,400 shares | +0% | - | |
| 25Weak | GLSIbuy Greenwich LifeSciences, Inc. | $24k 2,000 shares | +0% | - | |
| 30Weak | GLSIbuy Greenwich LifeSciences, Inc. | $27k 2,400 shares | +0% | - | |
| 26Weak | GLSIbuy Greenwich LifeSciences, Inc. | $36k 3,200 shares | +0% | - |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +1,800 | $29.83 | $54k | 5,604,102 | Jan 15, 2026 |
| Jan 12, 2026 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +2,900 | $27.54 | $80k | 5,602,302 | Jan 14, 2026 |
| Dec 31, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +4,300 | $21.36 | $92k | 5,599,402 | Jan 5, 2026 |
| Dec 30, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +2,900 | $21.73 | $63k | 5,595,102 | Jan 2, 2026 |
| Dec 18, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +4,100 | $12.62 | $52k | 5,592,202 | Dec 19, 2025 |
| Nov 25, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +4,600 | $8.37 | $39k | 5,588,102 | Nov 28, 2025 |
| Nov 13, 2025 | GLSI Greenwich LifeSciences, Inc. | AGrant or award Stock Optionsderivative | +100,000 | $0.00 | $0 | 2,347,462 | Nov 17, 2025 |
| Nov 7, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +10,600 | $8.43 | $89k | 5,583,502 | Nov 12, 2025 |
| Oct 31, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +2,300 | $9.26 | $21k | 5,572,902 | Nov 4, 2025 |
| Apr 25, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +3,600 | $9.88 | $36k | 5,570,602 | Apr 29, 2025 |
| Apr 17, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +5,400 | $8.98 | $48k | 5,567,002 | Apr 22, 2025 |
| Apr 7, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +3,600 | $9.10 | $33k | 5,561,602 | Apr 8, 2025 |
| Apr 4, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +5,500 | $8.73 | $48k | 5,558,002 | Apr 7, 2025 |
| Jan 10, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +2,500 | $12.51 | $31k | 5,552,502 | Jan 13, 2025 |
| Jan 6, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +1,100 | $13.31 | $15k | 5,548,202 | Jan 8, 2025 |
| Jan 7, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +1,800 | $13.75 | $25k | 5,550,002 | Jan 8, 2025 |
| Jan 3, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +3,400 | $12.95 | $44k | 5,547,102 | Jan 7, 2025 |
| Jan 2, 2025 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +2,000 | $11.97 | $24k | 5,543,702 | Jan 6, 2025 |
| Dec 31, 2024 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +2,400 | $11.36 | $27k | 5,541,702 | Jan 3, 2025 |
| Dec 30, 2024 | GLSI Greenwich LifeSciences, Inc. | POpen-market purchase Common Stock | +3,200 | $11.12 | $36k | 5,539,302 | Jan 2, 2025 |
| Dec 24, 2024 | GLSI Greenwich LifeSciences, Inc. | AGrant or award Stock Optionsderivative | +1,148,723 | $0.00 | $0 | 2,222,454 | Dec 27, 2024 |
| Dec 24, 2024 | GLSI Greenwich LifeSciences, Inc. | AGrant or award Stock Optionsderivativeindirect: By Wife | +25,008 | $0.00 | $0 | 2,247,462 | Dec 27, 2024 |
Questions about Snehal Patel
Answered from the filings on this page, as of the latest one.
Is Snehal Patel buying or selling?
In the last 12 months Snehal Patel reported 8 open-market buys worth $489k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $54k of GLSI on Jan 13, 2026. Grants, option exercises and tax withholding are not counted.
How did Snehal Patel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Snehal Patel has 0.
Where does Snehal Patel file Form 4?
Snehal Patel has filed Form 4 at GLSI (Greenwich LifeSciences, Inc.) as CEO and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.